echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Heart: How is obesity and weight loss related to heart failure?

    Heart: How is obesity and weight loss related to heart failure?

    • Last Update: 2020-09-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    This meta-analysis aims to determine the relationship between obesity and heart failure (HF) and the effects of intentional weight loss after bariatric surgery on the heart structure and heart muscle function of obese subjects.
    researchers looked at studies published by MEDLINE, Embase, and Web of Science prior to April 3, 2018, that reported the association and prognosory effects of obesity in HF, as well as studies on the effects of intentional weight loss after bariatric surgery on heart structure and cardiomyopathy in obese subjects.
    results, the researchers reviewed 4,959 citations.
    , 29 studies were analyzed.
    analysis showed a 'J-curve' relationship between body mass index (BMI) and HF risk, with pathologically obese people at the greatest risk (1.73 (95% CI 1.30 to 2.31), P.lt;0.001, n=11).
    'Obesity Paradox' was observed in all-cause mortality, although hyperrecombination was associated with lower cardiovascular (CV) mortality (OR=0.86 (95% CI 0.79-0.94), n=11), and there was no significant difference between the other BMI groups.
    In obese patients who did not identify HF, atrial fibrillation, or known coronary artery diseases, intentional weight loss induced by bariatric surgery was associated with a decrease in left room mass index (p.lt;0.0001), an improvement in left room clement function (p.0.0001) and a decrease in left atrial size (p.02).
    , although obesity increases the risk of HF, the 'obesity paradox' arises entirely from mortality.
    , however, the lowest CV mortality was observed in hyper-recombination.
    , intentional weight loss was associated with improved heart structure and heart muscle function indicators in obese patients.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.